Clinical doses of amikacin provide more effective suppression of the human CFTR-G542X stop mutation than gentamicin in a transgenic CF mouse model

Author: Du Ming   Keeling Kim   Fan Liming   Liu Xiaoli   Kovaçs Timea   Sorscher Eric   Bedwell David  

Publisher: Springer Publishing Company

ISSN: 0946-2716

Source: Journal of Molecular Medicine, Vol.84, Iss.7, 2006-07, pp. : 573-582

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content